| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/05/2005 | CN1560018A 2-(alpha-n-pentanone) phenmethyl and its preparation process and application |
| 01/05/2005 | CN1560000A Extraction process for total phenolic acid of salvia root and pharmacutical application thereof |
| 01/05/2005 | CN1559599A Medicine for treating angiocardiopathy and cerebrovascular disease |
| 01/05/2005 | CN1559587A Compound red sage dispersing tablet and its preparation method |
| 01/05/2005 | CN1559568A Pulse activiting medicinal preparation for injection and preparation method of its effective medicinal component |
| 01/05/2005 | CN1559565A Chinese medicinal preparation for treating cardiac blood vessel disease and its preparation method |
| 01/05/2005 | CN1559564A Supplementing qi pulse restoring Chinese medicinal preparation and its preparation method |
| 01/05/2005 | CN1559538A Compound Chinese medicinal extract mixture and its prepration method |
| 01/05/2005 | CN1559523A Naodesheng soft capsule and its preparation method |
| 01/05/2005 | CN1559499A Medicine for preventing apoplexy and its preparation method |
| 01/05/2005 | CN1559498A Ginkgo leaf extract and bimidamo oral compound medicine and its preparation method |
| 01/05/2005 | CN1559474A Chinese medicinal preparation of anti embolus disease and its preparation method |
| 01/05/2005 | CN1559473A Cinnamon twig decoction drop pill and its preparation method |
| 01/05/2005 | CN1559472A Astragalus injection Chinese medicinal preparation and its preparation method |
| 01/05/2005 | CN1559469A Prepn. method for freezing-drying powder injection for treating cardiovascular disease |
| 01/05/2005 | CN1559458A Novel use of extractive from sapan wood |
| 01/05/2005 | CN1559443A Sturgeon chondroition capsule and instant granula prepn. method therefor |
| 01/05/2005 | CN1559442A Soft capsule of dried oviduct fat of forest frog |
| 01/05/2005 | CN1559427A Medicine compound for treating cardiovascular and cerebrovascular diseases |
| 01/05/2005 | CN1559426A Medicine compound for treating cardiovascular and cerebrovascular diseases |
| 01/05/2005 | CN1559424A Erigeron breviscapus extraction dry suspensoid agent |
| 01/05/2005 | CN1559423A Oral effervesce tablets for treating cardiovascular and cerebrovascular diseases, and prepn. method therefor |
| 01/05/2005 | CN1559421A Medicine compound contg. troxeration |
| 01/05/2005 | CN1559407A Self-micro emulsion solft capsule of dihydropyridine type calcium ion agonist, and its prepn. method |
| 01/05/2005 | CN1559404A Method for preparing artemisine and its liposoluble derivatives emulsion |
| 01/05/2005 | CN1559402A Novel use of Brazil Hematine red |
| 01/05/2005 | CN1559401A Therapeutic use and compositions involving isoflavones |
| 01/05/2005 | CN1559399A Injection of haw leaf flavone prepn. method and use thereof |
| 01/05/2005 | CN1559397A Chrono-slow-releasing prepn. hydrochloride verapamil |
| 01/05/2005 | CN1559395A Freezing-drying compound contg. water-soluble gallopropylate and its prepn. method |
| 01/05/2005 | CN1559387A Intravenous injection liquid of coenzyme Q10, and its prepn. method |
| 01/05/2005 | CN1559385A Probucol solid dispersion tablets, and prepn. method therefor |
| 01/05/2005 | CN1183160C Human anti-factor IX/IXa antibodies |
| 01/05/2005 | CN1183157C Method for distillig active protein liquid of scorpion |
| 01/05/2005 | CN1183153C Orally active a1 adenosine receptor agonists |
| 01/05/2005 | CN1183150C Prepn process, medicine prepn and new medicinal use of sophoricosids |
| 01/05/2005 | CN1183149C Pharmaceutical compositions containing oligosaccharides and preparation thereof |
| 01/05/2005 | CN1183136C Indoloquinazolinones |
| 01/05/2005 | CN1183132C Tetracyclic azepinoindole compounds as 5-HT receptor ligands |
| 01/05/2005 | CN1183122C Dipeptide nitrile cathepsin K inhibitors |
| 01/05/2005 | CN1183119C Arylpiperzines as metalloproteinase inhibiting agents (MMP) and their use |
| 01/05/2005 | CN1183113C Tri-aryl acid derivatives as PPAR receptor ligands |
| 01/05/2005 | CN1183111C Cycloalkano-indole and cycloalkane-azaindole derivatives, process for their preparation and pharmaceutical commposition containing the same |
| 01/05/2005 | CN1183107C Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
| 01/05/2005 | CN1183098C 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof |
| 01/05/2005 | CN1182904C Methods for extraction and reaction using supercritical fluids |
| 01/05/2005 | CN1182874C Gene therapy for diabetic ischemic disease |
| 01/05/2005 | CN1182873C Arginine silicate inositol complex and use thereof |
| 01/05/2005 | CN1182869C Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restemosis |
| 01/05/2005 | CN1182867C Preparation of Chinese herbal medicine for treating sequela of apoplexy and its preparing method |
| 01/05/2005 | CN1182862C Chinese medicine prepn for treating coronary heart disease and angina pectoris and its prepn |
| 01/05/2005 | CN1182858C Heart-nourishing tea capsule and its prepn |
| 01/05/2005 | CN1182850C Preparation capable of regulating blood fat, blood pressure and blood sugar for protecting heart and brain cells and its prearing method |
| 01/04/2005 | US6838584 Estrogen receptor modulators |
| 01/04/2005 | US6838574 Induction cell differentiation; leukemia therapy |
| 01/04/2005 | US6838559 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease |
| 01/04/2005 | US6838476 Imidazoles with anti-inflammatory activity |
| 01/04/2005 | US6838470 Antiischemic agents; brain disorders; cardiovascular disorders |
| 01/04/2005 | US6838468 4-(phenyl-piperdin-4-ylidene methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 01/04/2005 | US6838466 Compounds for the treatment of inflammatory disorders |
| 01/04/2005 | US6838460 Substituted phenylamidines medicaments containing said compounds and method for production thereof |
| 01/04/2005 | US6838459 7-alkyl-and cycloalkyl-substituted imidazotriazinones |
| 01/04/2005 | US6838458 5-(alkylidene-cycloalkyl)-and 5-(alkylidene-heterocyclyl)-pyrazoles |
| 01/04/2005 | US6838456 Condensed pyridoindole derivatives |
| 01/04/2005 | US6838454 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 01/04/2005 | US6838453 Therapy for osteoporosis |
| 01/04/2005 | US6838452 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| 01/04/2005 | US6838442 Administering to said subject a jointly effective amount of a glucose reabsorption inhibitor; administering jointly effective amount of an retinoid-X receptor modulator for therapy of diabetes or Syndrome X |
| 01/04/2005 | US6838439 Heterocytes as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 01/04/2005 | US6838435 Grampositive, gramnegative bacteria; bactericides, fungicides; antibiotic resistance |
| 01/04/2005 | US6838433 Peptides used as inhibitors of interleukin-6 (IL-6), for prophylaxis, therapy and/or diagnosis of blood disorders such as leukemia |
| 01/04/2005 | US6838274 Urocortin proteins and uses thereof |
| 01/04/2005 | CA2350854C 1,4-dihydropyridine derivatives and methods of producing the same |
| 01/04/2005 | CA2340999C 5-arylindole derivatives |
| 01/04/2005 | CA2250929C 4-[(thien-2-yl)methyl]imidazole derivatives having alpha2-adrenoceptor agonistic activity |
| 12/30/2004 | US20040268425 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes; transgenic animals; dosage forms |
| 12/30/2004 | US20040268423 inhibiting formation of neurofibrillary tangles by reducing formation of a carboxyl-terminal truncated form of apolipoprotein E (apoE) in a neuron in the individual; animal models of Alzheimer's disease (AD); treating AD; drug screening |
| 12/30/2004 | US20040267028 Such as 2-amino-1-(2-chlorophenyl)-5-(4-chlorophenyl)-N-cyclohexyl-1H-pyrrole-3-carboxamide hydrochloride |
| 12/30/2004 | US20040267025 Compounds for the treatment of metabolic disorders |
| 12/30/2004 | US20040267016 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 12/30/2004 | US20040267012 5'-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 12/30/2004 | US20040267010 For therapy of central nervous system disorders |
| 12/30/2004 | US20040266989 Methods and compositions for the treatment of gastrointestinal disorders |
| 12/30/2004 | US20040266870 Inhibitors of the chemotactic activation induced by the fraction C5a of complement and from other chemotactic proteins (chemokines) that y activate a 7-transmembrane-domain receptor; psoriasis, rheumatoid arthritis, ulcerative colitis, acute respiratory distress syndrome, fibrosis; antiischemic agents |
| 12/30/2004 | US20040266864 Possess potent serotonin reuptake inhibitory activity, with minimal inhibitory effects on the reuptake of other known monoamines, e.g., norepinephrine or dopamine; also useful for treating or preventing other CNS disorders, cerebrovascular or vascular dysfunctions, sexual dysfunctiions, eating disorders |
| 12/30/2004 | US20040266842 Thiazolyl substituted triazoles as alk5 inhibitors |
| 12/30/2004 | US20040266841 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity |
| 12/30/2004 | US20040266839 2'-Methyl-5-(1,3,4-oxadiazol-2-yl)1,1'-biphenyl-4-carboxaide derivatives and their use as p38 kinase inhibitors |
| 12/30/2004 | US20040266836 Salt of acidic AT1-receptor antagonist and basic cardiovascular ingredient; potentiation or synergism; reduction of side effects |
| 12/30/2004 | US20040266826 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors |
| 12/30/2004 | US20040266823 Such as N-[1-(3-phenyl-3-benzoylamino]propyl)-4-piperidinyl]-N-ethylmethanesulfonylphenylacetamide; autoimmune and inflammatory diseases; rheumatoid arthritis; synthesis |
| 12/30/2004 | US20040266822 Secondary amines; tissue specificity; reduced side effects; cardiovascular diseases, diabetes, bronchial and urinary smooth muscle spasms, ischemia, anoxic nerve injury |
| 12/30/2004 | US20040266816 Potent and long lasting antimuscarinic agents; respiratory, urological or gastrointestinal disorders |
| 12/30/2004 | US20040266800 a selective N-alkylation reaction by adding a base; hydrolysing and amidating; useful for treating cardiovascular diseases caused by binding angiotensin II to its receptors, through antagonistic activity against angiotensin II receptors |
| 12/30/2004 | US20040266797 Use of potent,selective and non toxic c-kit inhibitors for treating tumor angiogensis |
| 12/30/2004 | US20040266793 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives for neurodegenerative disorders |
| 12/30/2004 | US20040266780 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 12/30/2004 | US20040266777 Pyridopyrazines and the use thereof as kinase inhibitors |
| 12/30/2004 | US20040266775 for human, veterinary, or phytoprotective use, e.g., inhibiting the cellular sodium-proton antiporter activity, for the treatment of cardiovascular diseases, metabolic diseases, cancerous diseases or fibrotic diseases |
| 12/30/2004 | US20040266772 Polymorph salt of a pryridazinone derivative for the treatment of arrythmia |